Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Buggisch

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Zeitschrift Fur Gastroenterologie|August 17, 2016
Chronic hepatitis C patients prior to broad access to interferon-free treatments in GermanyD Hüppe, P Buggisch, S Christensen, et al.
Zeitschrift Fur Gastroenterologie|July 14, 2015
Real-life experience with first generation HCV protease inhibitor therapy in Germany: The prospective, non-interventional PAN cohortS Mauss, K Böker, P Buggisch, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 1997
Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapy of pancreatic cancerW Schmiegel, J Schmielau, D Henne-Bruns, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II trial of 5-fluorouracil and recombinant interferon alfa-2B in metastatic colorectal carcinomaH J Weh, D Platz, D Braumann, et al.
Seminars in Oncology|April 1, 1992
Treatment of metastatic colorectal carcinoma with a combination of fluorouracil and recombinant interferon alfa-2b: preliminary data of a phase II studyH J Weh, D Platz, D Braumann, et al.
Journal of Viral Hepatitis|June 28, 2016
Hepatitis C viral dynamics during ribavirin priming differ according to prior treatment response and HCV typeB Fülöp, U Mihm, P Rohde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trialG Riethmüller, E Holz, G Schlimok, et al.
Zeitschrift Fur Gastroenterologie|February 3, 2023
[Strategietreffen: Virushepatitis in Deutschland eliminieren]T L Tergast, U Protzer, S Zeuzem, et al.
Journal of Viral Hepatitis|March 16, 2013
Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis BM Friedrich-Rust, P Buggisch, R J de Knegt, et al.
Zeitschrift Fur Gastroenterologie|June 18, 2009
The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infectionK Deterding, J Wiegand, N Grüner, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Zeitschrift Fur Gastroenterologie|August 17, 2016
Chronic hepatitis C patients prior to broad access to interferon-free treatments in GermanyD Hüppe, P Buggisch, S Christensen, et al.
Zeitschrift Fur Gastroenterologie|July 14, 2015
Real-life experience with first generation HCV protease inhibitor therapy in Germany: The prospective, non-interventional PAN cohortS Mauss, K Böker, P Buggisch, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 1997
Cytokine-mediated enhancement of epidermal growth factor receptor expression provides an immunological approach to the therapy of pancreatic cancerW Schmiegel, J Schmielau, D Henne-Bruns, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Phase II trial of 5-fluorouracil and recombinant interferon alfa-2B in metastatic colorectal carcinomaH J Weh, D Platz, D Braumann, et al.
Seminars in Oncology|April 1, 1992
Treatment of metastatic colorectal carcinoma with a combination of fluorouracil and recombinant interferon alfa-2b: preliminary data of a phase II studyH J Weh, D Platz, D Braumann, et al.
Journal of Viral Hepatitis|June 28, 2016
Hepatitis C viral dynamics during ribavirin priming differ according to prior treatment response and HCV typeB Fülöp, U Mihm, P Rohde, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trialG Riethmüller, E Holz, G Schlimok, et al.
Zeitschrift Fur Gastroenterologie|February 3, 2023
[Strategietreffen: Virushepatitis in Deutschland eliminieren]T L Tergast, U Protzer, S Zeuzem, et al.
Journal of Viral Hepatitis|March 16, 2013
Acoustic radiation force impulse imaging for non-invasive assessment of liver fibrosis in chronic hepatitis BM Friedrich-Rust, P Buggisch, R J de Knegt, et al.
Zeitschrift Fur Gastroenterologie|June 18, 2009
The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infectionK Deterding, J Wiegand, N Grüner, et al.
Pageof 3